Department of Gynaecology and Obstetrics, and Pathophysiology of Human Reproduction, University of Naples "Federico II", Via Pansini 5, 80131 Naples, Italy.
Department of Gynaecology and Obstetrics, and Pathophysiology of Human Reproduction, University of Naples "Federico II", Via Pansini 5, 80131 Naples, Italy.
Gynecol Oncol. 2014 Sep;134(3):556-60. doi: 10.1016/j.ygyno.2014.06.015. Epub 2014 Jun 23.
Lymphoceles are among the most common post-operative complications of pelvic lymphadenectomy, with a reported incidence of 1% to 29% in gynecology oncology. Several studies evaluated the effectiveness of biological glues on reducing lymphoceles, but no data on gynecological patients are available. We evaluated the effectiveness of cyanoacrylic glues (n-butyl cyanoacrylate) (Glubran 2 - GEM s.r.l., Italy) in preventing lymphocele on 30 patients who underwent pelvic lymphadenectomy for endometrial or cervical cancer.
Single-blind prospective randomized study. Patients were divided into 2 groups: pelvic lymphadenectomy plus n-butyl cyanoacrylate (treatment group: 44 patients) and pelvic lymphadenectomy without n-butyl cyanoacrylate (control group: 44 patients). Primary endpoint was incidence of pelvic lymphocele in the two groups 30 days after surgery, and evaluated with pelvic ultrasound and RMI examination. Secondary endpoints evaluated drainage volume of lymphorrhea 36, 48, 72 and 96 h after surgery.
15% in the treatment group and 36.6% in the control group had lymphocele 1month after the procedure (p<0.03; RR 0.4 [95% CI 0.152-0.999]). Concerning the secondary outcome in group A the amount of lymphorrhea presented a constant significant decrease during evaluation; on the contrary, in group B, after an initial decrease at 48 h, the amount of lymphorrhea remained unchanged; at all considered times the amount of lymphorrhea resulted significantly greater in controls.
Intraoperative application of n-butyl cyanoacrylate seems to reduce lymph production after pelvic lymphadenectomy, providing a useful additional treatment option for reducing drainage volume and preventing lymphocele development after pelvic lymphadenectomy.
淋巴结囊肿是盆腔淋巴结清扫术后最常见的并发症之一,在妇科肿瘤学中报道的发病率为 1%至 29%。有几项研究评估了生物胶在减少淋巴结囊肿方面的有效性,但尚无妇科患者的数据。我们评估了氰基丙烯酸酯胶(正丁基氰基丙烯酸酯)(Glubran 2-GEM s.r.l.,意大利)在预防 30 名接受子宫内膜或宫颈癌盆腔淋巴结清扫术的患者发生淋巴结囊肿的有效性。
单盲前瞻性随机研究。患者分为两组:盆腔淋巴结清扫术加正丁基氰基丙烯酸酯(治疗组:44 例)和盆腔淋巴结清扫术不加正丁基氰基丙烯酸酯(对照组:44 例)。主要终点是两组患者术后 30 天的盆腔淋巴结囊肿发生率,并通过盆腔超声和 RMI 检查进行评估。次要终点评估术后 36、48、72 和 96 小时的淋巴漏引流量。
治疗组有 15%,对照组有 36.6%的患者在手术后 1 个月发生淋巴结囊肿(p<0.03;RR 0.4 [95%CI 0.152-0.999])。关于 A 组的次要结局,淋巴漏的量在评估过程中持续显著减少;相反,在 B 组中,在 48 小时初始减少后,淋巴漏的量保持不变;在所有考虑的时间点,对照组的淋巴漏量明显更大。
术中应用正丁基氰基丙烯酸酯似乎可以减少盆腔淋巴结清扫术后的淋巴生成,为减少引流量和预防盆腔淋巴结清扫术后淋巴结囊肿的发生提供了一种有用的额外治疗选择。